Celgene In Talks To Buy Juno Therapeutics
Jan 17, 2018, 10:29 AM
by
Michael Croft
New York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.
January 17, 2018 | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction. New York Business Journal